-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
-
Summary
-
Kyverna Therapeutics, Inc. quarterly Accounts Payable, Current history and growth rate from Q4 2023 to Q3 2024.
- Kyverna Therapeutics, Inc. Accounts Payable, Current for the quarter ending September 30, 2024 was $9.93M.
Accounts Payable, Current, Quarterly (USD)